J Korean Med Sci.  2022 Aug;37(33):e261. 10.3346/jkms.2022.37.e261.

Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?

• Jang BK

• KMID: 2532634
• DOI: http://doi.org/10.3346/jkms.2022.37.e261

Reference

1. Lewis JH. The art and science of diagnosing and managing drug-induced liver injury in 2015 and beyond. Clin Gastroenterol Hepatol. 2015; 13(12):2173–2189.e8. PMID: 26116527.

2. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002; 36(2):451–455. PMID: 12143055.

3. Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013; 144(7):1419–1425. 1425.e1–1413. quiz e19-20. PMID: 23419359.

4. Gallo G, Volpe M, Rubattu S. Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations. Vasc Health Risk Manag. 2022; 18:507–515. PMID: 35846737.

5. Choi WJ, Kim GA, Park J, Jang S, Jung WJ, Shin JJ, et al. Incidence and pattern of aminotransferase elevation during anti-hypertensive therapy with angiotensin-II receptor blockers. J Korean Med Sci. 2022; 37(33):e255. PMID: 35996932.